Nicholas Donoghoe
CIK: 0001762951
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AbbVie Inc.
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Aug 14, 2026ABBV
AbbVie Inc.
Sale(S)Direct32.7K shares at avg. $250.00$8.2M - Aug 14, 2026ABBV
AbbVie Inc.
Exercise(M)Direct32.7K shares at avg. $79.02$2.6M - Feb 27, 2026ABBV
AbbVie Inc.
Tax Payment(F)Direct12.9K shares at avg. $232.08$3.0M - Feb 18, 2026ABBV
AbbVie Inc.
Award(A)Direct13K shares- - Feb 18, 2026ABBV
AbbVie Inc.
Award(A)Direct4.6K shares- - Feb 18, 2026ABBV
AbbVie Inc.
Award(A)Direct5.2K shares- - Feb 18, 2026ABBV
AbbVie Inc.
Award(A)Direct6.2K shares- - Aug 5, 2025ABBV
AbbVie Inc.
Sale(S)Direct10.1K shares at avg. $198.59$2.0M - Aug 5, 2025ABBV
AbbVie Inc.
Sale(S)Direct3.2K shares at avg. $198.27$641K - Feb 28, 2025ABBV
AbbVie Inc.
Tax Payment(F)Direct11.2K shares at avg. $205.02$2.3M - Feb 13, 2025ABBV
AbbVie Inc.
Award(A)Direct11K shares- - Feb 13, 2025ABBV
AbbVie Inc.
Award(A)Direct4.6K shares- - Feb 13, 2025ABBV
AbbVie Inc.
Award(A)Direct5.2K shares- - Feb 13, 2025ABBV
AbbVie Inc.
Award(A)Direct4.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 14, 2026 | ABBV AbbVie Inc. | Sale(S) | 32,710 | $250.00 | $8,177,500 | Direct |
| Aug 14, 2026 | ABBV AbbVie Inc. | Exercise(M) | 32,710 | $79.02 | $2,584,744 | Direct |
| Feb 27, 2026 | ABBV AbbVie Inc. | Tax Payment(F) | 12,874 | $232.08 | $2,987,798 | Direct |
| Feb 18, 2026 | ABBV AbbVie Inc. | Award(A) | 13,031 | - | $0 | Direct |
| Feb 18, 2026 | ABBV AbbVie Inc. | Award(A) | 4,632 | - | $0 | Direct |
| Feb 18, 2026 | ABBV AbbVie Inc. | Award(A) | 5,172 | - | $0 | Direct |
| Feb 18, 2026 | ABBV AbbVie Inc. | Award(A) | 6,222 | - | $0 | Direct |
| Aug 5, 2025 | ABBV AbbVie Inc. | Sale(S) | 10,061 | $198.59 | $1,998,014 | Direct |
| Aug 5, 2025 | ABBV AbbVie Inc. | Sale(S) | 3,234 | $198.27 | $641,239 | Direct |
| Feb 28, 2025 | ABBV AbbVie Inc. | Tax Payment(F) | 11,230 | $205.02 | $2,302,375 | Direct |
| Feb 13, 2025 | ABBV AbbVie Inc. | Award(A) | 11,017 | - | - | Direct |
| Feb 13, 2025 | ABBV AbbVie Inc. | Award(A) | 4,634 | - | - | Direct |
| Feb 13, 2025 | ABBV AbbVie Inc. | Award(A) | 5,174 | - | - | Direct |
| Feb 13, 2025 | ABBV AbbVie Inc. | Award(A) | 4,520 | - | - | Direct |
1-14 of 14 transactions
About Donoghoe Nicholas
Donoghoe Nicholas (SEC CIK 0001762951) files insider reports with the SEC as EVP, CHIEF BUS/STRAT OFFICER of AbbVie Inc. (ABBV).
Signal8 holds 6 ownership filings by Donoghoe Nicholas, all Form 4s, filed between Feb 18, 2025 and Aug 18, 2026. Those filings report 14 transactions, from Feb 13, 2025 to Aug 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Donoghoe Nicholas's filings is in NORTH CHICAGO, IL.
Recent filings by Donoghoe Nicholas
- Aug 14, 2026: Open-market sale of ABBV shares (Form 4, code S).
- Aug 14, 2026: Option exercise of ABBV shares (Form 4, code M).
- Feb 27, 2026: Tax withholding of ABBV shares (Form 4, code F).
- Feb 18, 2026: Grants or awards of ABBV shares (4 lines, Form 4, code A).
- Aug 5, 2025: Open-market sales of ABBV shares (2 lines, Form 4, code S).
Other insiders filing for AbbVie Inc. (ABBV)
- Carethers John, Director
- Quaggin Susan E, Director
- RAPP EDWARD J, Director
- FALK THOMAS J, Director
- WADDELL FREDERICK H, Director
- Roberts Rebecca B, Director